1043 related articles for article (PubMed ID: 25694464)
1. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
[TBL] [Abstract][Full Text] [Related]
2. Statin-associated muscle symptoms EAS Consensus Panel paper focuses on this neglected patient group.
Stock J
Atherosclerosis; 2015 Sep; 242(1):346-50. PubMed ID: 26253793
[No Abstract] [Full Text] [Related]
3. Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy.
Vinci P; Panizon E; Tosoni LM; Cerrato C; Pellicori F; Mearelli F; Biasinutto C; Fiotti N; Di Girolamo FG; Biolo G
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769118
[TBL] [Abstract][Full Text] [Related]
4. Curcumin: An effective adjunct in patients with statin-associated muscle symptoms?
Sahebkar A; Saboni N; Pirro M; Banach M
J Cachexia Sarcopenia Muscle; 2017 Feb; 8(1):19-24. PubMed ID: 27897416
[TBL] [Abstract][Full Text] [Related]
5. Statin associated muscle symptoms (SAMS): strategies for prevention, assessment and management.
Iatan I; Mancini GBJ; Yeoh E; Hegele RA
Expert Rev Cardiovasc Ther; 2023 Jun; 21(6):423-435. PubMed ID: 37212306
[TBL] [Abstract][Full Text] [Related]
6. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
7. Statin intolerance - an attempt at a unified definition. Position paper from an International Lipid Expert Panel.
Banach M; Rizzo M; Toth PP; Farnier M; Davidson MH; Al-Rasadi K; Aronow WS; Athyros V; Djuric DM; Ezhov MV; Greenfield RS; Hovingh GK; Kostner K; Serban C; Lighezan D; Fras Z; Moriarty PM; Muntner P; Goudev A; Ceska R; Nicholls SJ; Broncel M; Nikolic D; Pella D; Puri R; Rysz J; Wong ND; Bajnok L; Jones SR; Ray KK; Mikhailidis DP
Expert Opin Drug Saf; 2015 Jun; 14(6):935-55. PubMed ID: 25907232
[TBL] [Abstract][Full Text] [Related]
8. Statin-Associated Muscle Disease: Advances in Diagnosis and Management.
Taylor BA; Thompson PD
Neurotherapeutics; 2018 Oct; 15(4):1006-1017. PubMed ID: 30251222
[TBL] [Abstract][Full Text] [Related]
9. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
10. Statin Intolerance: A Review and Update.
Tsushima Y; Hatipoglu B
Endocr Pract; 2023 Jul; 29(7):566-571. PubMed ID: 36958647
[TBL] [Abstract][Full Text] [Related]
11. Statin intolerance.
Laufs U; Scharnagl H; März W
Curr Opin Lipidol; 2015 Dec; 26(6):492-501. PubMed ID: 26780003
[TBL] [Abstract][Full Text] [Related]
12. An overview of statin-induced myopathy and perspectives for the future.
Nikolic D; Banach M; Chianetta R; Luzzu LM; Pantea Stoian A; Diaconu CC; Citarrella R; Montalto G; Rizzo M
Expert Opin Drug Saf; 2020 May; 19(5):601-615. PubMed ID: 32233708
[No Abstract] [Full Text] [Related]
13. Statin intolerance.
Ahmad Z
Am J Cardiol; 2014 May; 113(10):1765-71. PubMed ID: 24792743
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of statin-associated skeletal muscle-associated symptoms.
Bouitbir J; Sanvee GM; Panajatovic MV; Singh F; Krähenbühl S
Pharmacol Res; 2020 Apr; 154():104201. PubMed ID: 30877064
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Statin Intolerance.
Alonso R; Cuevas A; Cafferata A
J Atheroscler Thromb; 2019 Mar; 26(3):207-215. PubMed ID: 30662020
[TBL] [Abstract][Full Text] [Related]
16. 2019 Taiwan Society of Lipids and Atherosclerosis expert consensus statement on statin intolerance.
Chien SC; Chen PS; Huang YH; Tang SC; Li YH; Yeh HI
J Formos Med Assoc; 2019 Oct; 118(10):1385-1392. PubMed ID: 30584005
[TBL] [Abstract][Full Text] [Related]
17. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
Sullivan D; Olsson AG; Scott R; Kim JB; Xue A; Gebski V; Wasserman SM; Stein EA
JAMA; 2012 Dec; 308(23):2497-506. PubMed ID: 23128163
[TBL] [Abstract][Full Text] [Related]
18. Practical aspects in the management of statin-associated muscle symptoms (SAMS).
Laufs U; Filipiak KJ; Gouni-Berthold I; Catapano AL;
Atheroscler Suppl; 2017 Apr; 26():45-55. PubMed ID: 28434484
[TBL] [Abstract][Full Text] [Related]
19. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.
Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A
Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054
[TBL] [Abstract][Full Text] [Related]
20. Assessment and management of statin-associated muscle symptoms (SAMS): A clinical perspective from the National Lipid Association.
Warden BA; Guyton JR; Kovacs AC; Durham JA; Jones LK; Dixon DL; Jacobson TA; Duell PB
J Clin Lipidol; 2023; 17(1):19-39. PubMed ID: 36115813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]